Business Daily Media

The Times Real Estate

.

Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market

HONG KONG SAR - EQS Newswire - 2 December 2024 - Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group") is pleased to announce two significant milestones that demonstrate the Group's continued growth and innovation in the field of medical aesthetics and dermatological solutions.



Group photo of the launch of 肌顏態®
Group photo of the launch of 肌顏態®

The Group's strategic cooperation product with Chongqing Minji Medical Device Co., Ltd., recombinant collagen dressing, has successfully received Class II medical device approval, with the approval number "渝械注准 20242140377". At the same time, the Group's self-developed medical aesthetics product, 肌顏態®, was successfully launched, marked by a grand event held in Wuhan. The launch brought together industry experts, key opinion leaders, media representatives, and other professionals to witness the Group's entry into the rapidly growing medical aesthetics market, valued at hundreds of billions of RMB. This milestone signifies a bold new chapter for the Group as it continues to expand its presence in this high-potential sector.

Collagen, which is central to the newly approved recombinant collagen dressing, is the most abundant protein in the human body, comprising 25–35% of total protein content. It forms a network of elastic fibers that support the skin's structure, maintain elasticity, and lock in moisture. However, collagen production decreases by approximately 1% annually after maturity (around age 21), leading to a loss of skin firmness and elasticity. Collagen-based products have a wide range of applications, including moisturizing, maintaining the skin barrier, and addressing signs of aging. In addition to dressing, microneedles for collagen are also being developed.

The launch of 肌顏態®, developed based on proprietary patents of Skbrella™ FN (Recombinant Human Fibronectin), marks another key milestone in the Group's efforts to expand its portfolio. 肌顏態® is designed to provide safe, effective solutions for improving skin quality and repair, making it ideal for treating damaged skin, acne-prone skin, and for post-medical procedure care. Fibronectin, a multifunctional extracellular matrix glycoprotein, plays a vital role in cell migration, adhesion, proliferation, hemostasis, and tissue repair. It is worth mentioning that the Group is advancing the development of its fibronectin-based medical device.

Photo left:肌顏態® Fibronectin Repair Solution; Photo right:肌顏態® Fibronectin Serum
Photo left:肌顏態® Fibronectin Repair Solution; Photo right:肌顏態® Fibronectin Serum

The debut of肌顏態® has attracted high recognition and attention from many dermatologists and medical aesthetics practitioners. At the launch, experts and scholars conducted professional academic exchanges and case sharing on the effects and clinical use of fibronectin from different perspectives "肌顏態®, a product designed for use throughout the entire cycle of preoperative and post-medical procedures, demonstrates significant effectiveness, particularly for patients with anesthetic allergies. It enables rapid skin repair and reduces redness efficiently."

Dermatology clinical practice sharing by Professor Yang Bin, President of Guangdong Dermatology Hospital, Southern Medical University
Dermatology clinical practice sharing by Professor Yang Bin, President of Guangdong Dermatology Hospital, Southern Medical University
肌顏態® use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University
肌顏態® use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University

Mr. Frank Zhao, CEO of Uni-Bio Science Group, also said: "The Group will leverage its professional expertise in dermatology, nearly three decades robust clinical data from GeneTime , and its established sales network, adhering to the rigorous R&D standards of pharmaceutical companies, to build a diversified product portfolio across biological drugs, medical devices, and medical aesthetics, ultimately providing safer and more effective full-cycle skincare solutions for patients."

Photo left: Mr. Frank Zhao, CEO of Uni-Bio Science Group delivered opening speech for the launch of 肌顏態®; Photo right: Dr. Yu Shan, Deputy Director of R&D and Project of Uni-Bio Science Group, introduction of 肌顏態®
Photo left: Mr. Frank Zhao, CEO of Uni-Bio Science Group delivered opening speech for the launch of 肌顏態®; Photo right: Dr. Yu Shan, Deputy Director of R&D and Project of Uni-Bio Science Group, introduction of 肌顏態®

The Group is well-positioned to capitalize on the growing opportunities in the market. Industry forecasts indicate that the medical aesthetic market is set to sustain a CAGR growth of 10% to 15% between 2024 and 2027, and is expected to exceed RMB 600 billion in 2030. The approval of collagen medical devices and the launch of 肌顏態® herald a new journey for the Group in the field of skin care.

Mr. Kingsley Leung, Chairman of Uni-Bio Science Group, success entered in partnerships with various renowned medical aesthetics clinic chain and distributors
Mr. Kingsley Leung, Chairman of Uni-Bio Science Group, success entered in partnerships with various renowned medical aesthetics clinic chain and distributors

These achievements reflect the Group's strong commitment to innovation, strategic execution, and value creation. As the Group continues to execute its strategic vision, it remains focused on its goal of becoming China's leading expert in dermatology, leveraging innovation, clinical expertise, and market insight to drive sustainable growth and long-term success.

Hashtag: #Uni-BioScience

The issuer is solely responsible for the content of this announcement.

News from Asia

LFC and adidas reunite with new multi-year partnership

LIVERPOOL, UK - Media OutReach Newswire - 13 March 2025 - Liverpool Football Club and adidas have agreed a new multi-year partnership that will see the sportswear giant once again become the club...

Prince Holding Group Earns Fifth Consecutive ‘Best in Cambodia’ Award for CSR Initiatives

Recognized at the 17th Annual Global CSR & ESG Awards for Sustainable Development Efforts PHNOM PENH, CAMBODIA - Media OutReach Newswire - 13 March 2025 - Prince Holding Group has been recogni...

Galaxy Macau’s Reveals a Galaxy of Stars As the Integrated Resort’s Restaurants are Awarded Five Michelin Stars in the 17th Michelin Guide Hong Kong Macau 2025

Sushi Kissho by Miyakawa Celebrates a Stellar Debut MACAU SAR - Media OutReach Newswire - 13 March 2025 - In the 17th Michelin Guide Hong Kong Macau 2025, Galaxy Macau™, the world-class luxury in...

Melco continues to lead with the city’s top number of Stars granted by MICHELIN Guide Hong Kong & Macau 2025

MACAO SAR - Media OutReach Newswire - 13 March 2025 - Melco Resorts & Entertainment continues to lead in Macau in the newly published MICHELIN Guide Hong Kong & Macau 2025, being granted ...

Singapore G Unveils the Largest Cold Storage Facility in Central Singapore, Reinforcing Its Commitment to Supporting SMEs and Business Growth

SINGAPORE - Media OutReach Newswire - 14 March 2025 - Singapore G, a trailblazer in space solutions, today announced the grand opening of MustardSeed@SG Cold Store, a cold storage facility in the ...

GROW with Singlife and aberdeen Launch New Exclusive Share Class of Global Income Bond Fund to Deliver Sustainable Payouts Amid Market Volatility

Globally diversified portfolio of crossover bonds aims to deliver attractive yields for investors SINGAPORE - Media OutReach Newswire - 14 March 2025 - GROW with Singlife ("GROW"), the integrated...

Konica Minolta wins 2025 A3 Line of the Year Award and four Pick Awards from Keypoint Intelligence

Recognition of Konica Minolta’s adaptable, future-ready innovations in office printing technology. SINGAPORE - Media OutReach Newswire - 14 March 2025 – Konica Minolta has been awarded five ...

Silver vs. Gold: Octa Broker's Expert Take on the Future of Precious Metals

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 14 March 2025 - Silver is attracting investor interest, with market analysts predicting a potential leap to $40 per troy ounce in 2025...

Asia trade set for continued growth despite challenging global business environment, reveals DHL Trade Atlas 2025

India, Vietnam, Indonesia, and the Philippines are forecast to lead in both speed and scale of trade growth from 2024 to 2029 South Asia and Southeast Asia regions set to ach...

Incode joins Australia’s Age Assurance Technology Trial to protect children online

With a market-leading +99% accuracy rate, Incode will play a key role in safeguarding Aussie minors on social media Incode Technologies Inc., a...

Empowering small businesses: Localsearch rolls out affordable digital solutions

New suite of digital solutions designed to boost visibility, engagement, and customer acquisition In response to a rapidly evolving digital lan...

Why Responsible Leadership is a Competitive Advantage for Small Businesses

In today’s fast-changing business landscape, leadership is evolving. While large corporations are reassessing their diversity, equity, and inclusi...

Why it’s a great time to include the EU in your export push

With the US market beset with unknowns, training your sights on mainland Europe in 2025 makes sound sense. Wondering whether the introduction o...

Success Isn’t About Labels—It’s About Mindset

In the lead up to International Women’s Day, I’ve been reflecting on my own success as a business owner and whether or not being a woman has playe...

Accelerate Action- Thryv champions women in business for International Women’s Day

Thryv® (NASDAQ: THRY), provider of the leading small business software platform, is celebrating International Women’s Day by shining a spotlight o...

Sell by LayBy